Ensysce Biosciences Stock Jumps 48% Premarket, Nasdaq Compliance Still Elusive
Ensysce Biosciences (NASDAQ:ENSC) shares jumped 48% in premarket trading, yet the stock remains 141% below the $1 minimum bid price required by Nasdaq. The compliance window begins August 11.
Markets